Logo image of BNZI

BANZAI INTERNATIONAL INC (BNZI) Stock Fundamental Analysis

NASDAQ:BNZI - Nasdaq - US06682J3086 - Common Stock - Currency: USD

2.24  +0.31 (+16.06%)

After market: 2.06 -0.18 (-8.04%)

Fundamental Rating

1

Taking everything into account, BNZI scores 1 out of 10 in our fundamental rating. BNZI was compared to 286 industry peers in the Software industry. Both the profitability and financial health of BNZI have multiple concerns. BNZI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BNZI has reported negative net income.
BNZI Yearly Net Income VS EBIT VS OCF VS FCFBNZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of BNZI (-197.02%) is worse than 96.06% of its industry peers.
Industry RankSector Rank
ROA -197.02%
ROE N/A
ROIC N/A
ROA(3y)-83.21%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNZI Yearly ROA, ROE, ROICBNZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200

1.3 Margins

With a Gross Margin value of 68.33%, BNZI perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for BNZI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BNZI Yearly Profit, Operating, Gross MarginsBNZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

BNZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BNZI has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BNZI is higher compared to a year ago.
BNZI Yearly Shares OutstandingBNZI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
BNZI Yearly Total Debt VS Total AssetsBNZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

BNZI has an Altman-Z score of -21.15. This is a bad value and indicates that BNZI is not financially healthy and even has some risk of bankruptcy.
BNZI has a Altman-Z score of -21.15. This is amonst the worse of the industry: BNZI underperforms 94.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.15
ROIC/WACCN/A
WACC12.1%
BNZI Yearly LT Debt VS Equity VS FCFBNZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.17 indicates that BNZI may have some problems paying its short term obligations.
BNZI has a worse Current ratio (0.17) than 97.49% of its industry peers.
BNZI has a Quick Ratio of 0.17. This is a bad value and indicates that BNZI is not financially healthy enough and could expect problems in meeting its short term obligations.
BNZI's Quick ratio of 0.17 is on the low side compared to the rest of the industry. BNZI is outperformed by 97.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
BNZI Yearly Current Assets VS Current LiabilitesBNZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BNZI have decreased strongly by -13725.89% in the last year.
EPS 1Y (TTM)-13725.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BNZI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.83% yearly.
Based on estimates for the next years, BNZI will show a very strong growth in Revenue. The Revenue will grow by 29.51% on average per year.
EPS Next Y42.16%
EPS Next 2Y28.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.58%
Revenue Next 2Y29.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BNZI Yearly Revenue VS EstimatesBNZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2M 4M 6M
BNZI Yearly EPS VS EstimatesBNZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNZI. In the last year negative earnings were reported.
Also next year BNZI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNZI Price Earnings VS Forward Price EarningsBNZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNZI Per share dataBNZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

A more expensive valuation may be justified as BNZI's earnings are expected to grow with 28.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.83%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BNZI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BANZAI INTERNATIONAL INC

NASDAQ:BNZI (1/30/2025, 8:07:41 PM)

After market: 2.06 -0.18 (-8.04%)

2.24

+0.31 (+16.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners6.16%
Inst Owner Change0%
Ins Owners0.67%
Ins Owner Change-0.68%
Market Cap13.87M
Analysts82.86
Price Target127.5 (5591.96%)
Short Float %6.17%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.25%
Min EPS beat(2)-13.12%
Max EPS beat(2)41.61%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.35%
Min Revenue beat(2)-11.76%
Max Revenue beat(2)-10.93%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4900%
EPS NY rev (1m)0%
EPS NY rev (3m)-4900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.91%
Revenue NY rev (1m)-14.35%
Revenue NY rev (3m)-14.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-44.97
EYN/A
EPS(NY)-15.3
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.74
BVpS-3.69
TBVpS-4.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -197.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.33%
FCFM N/A
ROA(3y)-83.21%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -21.15
F-ScoreN/A
WACC12.1%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13725.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.64%
EPS Next Y42.16%
EPS Next 2Y28.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year5.58%
Revenue Next 2Y29.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-202.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.54%
OCF growth 3YN/A
OCF growth 5YN/A